Quipt Home Medical Corp. (NASDAQ:QIPT – Get Free Report) has earned an average recommendation of “Buy” from the six ratings firms that are covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell rating, three have given a buy rating and two have issued a strong buy rating on the company. The average 1-year target price among brokerages that have issued ratings on the stock in the last year is $6.25.
Several research firms recently issued reports on QIPT. Ventum Cap Mkts raised shares of Quipt Home Medical to a “strong-buy” rating in a report on Tuesday, July 16th. Benchmark cut their target price on shares of Quipt Home Medical from $9.00 to $7.00 and set a “buy” rating for the company in a research note on Wednesday, August 21st. Finally, Canaccord Genuity Group dropped their price objective on shares of Quipt Home Medical from $8.00 to $6.00 and set a “buy” rating for the company in a research note on Friday, August 16th.
View Our Latest Stock Analysis on Quipt Home Medical
Institutional Investors Weigh In On Quipt Home Medical
Quipt Home Medical Trading Down 1.8 %
Shares of NASDAQ:QIPT opened at $2.76 on Tuesday. The company has a current ratio of 1.11, a quick ratio of 0.77 and a debt-to-equity ratio of 0.66. The company has a 50 day moving average of $3.02 and a 200-day moving average of $3.39. Quipt Home Medical has a twelve month low of $2.60 and a twelve month high of $5.29. The firm has a market cap of $117.50 million, a P/E ratio of -27.60 and a beta of 0.60.
Quipt Home Medical (NASDAQ:QIPT – Get Free Report) last released its quarterly earnings data on Wednesday, August 14th. The company reported ($0.04) earnings per share for the quarter, missing the consensus estimate of $0.01 by ($0.05). The company had revenue of $63.97 million during the quarter, compared to analyst estimates of $65.03 million. Quipt Home Medical had a negative net margin of 1.95% and a negative return on equity of 4.51%. During the same quarter in the prior year, the company posted ($0.03) EPS. As a group, analysts anticipate that Quipt Home Medical will post -0.1 earnings per share for the current fiscal year.
Quipt Home Medical Company Profile
Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment.
Recommended Stories
- Five stocks we like better than Quipt Home Medical
- About the Markup Calculator
- When Is the Best Time to Invest in Mutual Funds?
- Golden Cross Stocks: Pattern, Examples and Charts
- Is NVIDIA Stock in a Correction or Consolidation?
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- 3 Oversold Stocks with Big RSI Rebound Potential
Receive News & Ratings for Quipt Home Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quipt Home Medical and related companies with MarketBeat.com's FREE daily email newsletter.